Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics. 2014;13(3):907-17. doi:10.1074/mcp.M113.036095
Choudhary A, He KH, Mertins P, et al. Quantitative-proteomic comparison of alpha and Beta cells to uncover novel targets for lineage reprogramming. PLoS One. 2014;9(4):e95194. doi:10.1371/journal.pone.0095194
Lassen KG, Kuballa P, Conway KL, et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense. Proc Natl Acad Sci U S A. 2014;111(21):7741-6. doi:10.1073/pnas.1407001111
Broudy D, Killeen T, Choi M, et al. A framework for installable external tools in Skyline. Bioinformatics. 2014;30(17):2521-3. doi:10.1093/bioinformatics/btu148
Lundby A, Rossin EJ, Steffensen AB, et al. Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nat Methods. 2014;11(8):868-74. doi:10.1038/nmeth.2997
Whiteaker JR, Halusa GN, Hoofnagle AN, et al. CPTAC Assay Portal: a repository of targeted proteomic assays. Nat Methods. 2014;11(7):703-4. doi:10.1038/nmeth.3002
Zhang B, Wang J, Wang X, et al. Proteogenomic characterization of human colon and rectal cancer. Nature. 2014;513(7518):382-7. doi:10.1038/nature13438
Olson DE, Udeshi ND, Wolfson NA, et al. An unbiased approach to identify endogenous substrates of "histone" deacetylase 8. ACS Chem Biol. 2014;9(10):2210-6. doi:10.1021/cb500492r
Naba A, Clauser KR, Whittaker CA, Carr SA, Tanabe KK, Hynes RO. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer. 2014;14:518. doi:10.1186/1471-2407-14-518
Creech AL, Taylor JE, Maier VK, et al. Building the Connectivity Map of epigenetics: chromatin profiling by quantitative targeted mass spectrometry. Methods. 2015;72:57-64. doi:10.1016/j.ymeth.2014.10.033